Thyroid cancer

DW Chen, BHH Lang, DSA McLeod, K Newbold… - The Lancet, 2023 - thelancet.com
The past 5–10 years have brought in a new era in the care of patients with thyroid cancer,
with the introduction of transformative diagnostic and management options. Several …

Current controversies in low-risk differentiated thyroid cancer: reducing overtreatment in an era of overdiagnosis

TM Ullmann, M Papaleontiou… - The Journal of Clinical …, 2023 - academic.oup.com
Context Low-risk differentiated thyroid cancer (DTC) is overdiagnosed, but true incidence
has increased as well. Owing to its excellent prognosis with low morbidity and mortality …

Active surveillance of papillary thyroid cancer: frequency and time course of the six most common tumor volume kinetic patterns

RM Tuttle, J Fagin, G Minkowitz, R Wong, B Roman… - Thyroid, 2022 - liebertpub.com
Background: The change in size of the papillary thyroid cancer (PTC) nodule during active
surveillance has traditionally been characterized as either stable, increasing, or decreasing …

Progression of low-risk papillary thyroid microcarcinoma during active surveillance: interim analysis of a multicenter prospective cohort study of active surveillance on …

EK Lee, JH Moon, Y Hwangbo, CH Ryu, SW Cho… - Thyroid, 2022 - liebertpub.com
Background: Active surveillance (AS) is an alternative to thyroidectomy for the management
of low-risk papillary thyroid microcarcinoma (PTMC). However, prospective AS data …

Active surveillance of differentiated thyroid cancer metastatic cervical lymph nodes: a retrospective single-center cohort study

LB Walter, RS Scheffel, AB Zanella, M Farenzena… - Thyroid, 2023 - liebertpub.com
Background: The most frequent site of recurrence of differentiated thyroid cancer (DTC) is
cervical lymph nodes (LNs), which often necessitates repeated surgical interventions and …

[HTML][HTML] Percutaneous ablation of low-risk papillary thyroid cancer

RM Tuttle, D Li, F Ridouani - Endocrine-Related Cancer, 2023 - erc.bioscientifica.com
Graphical abstract Abstract Minimalistic management options such as active surveillance
and thyroid lobectomy are increasingly being accepted as reasonable management options …

Surgical outcomes in patients with low-risk papillary thyroid microcarcinoma from maestro study: immediate operation versus delayed operation after active …

H Hwang, JY Choi, HW Yu, JH Moon, J Kim… - Annals of …, 2023 - journals.lww.com
Objective: To investigate surgical, and clinical outcomes in patients with low-risk papillary
thyroid microcarcinoma (PTMC) according to treatment options [immediate operation (IOP) …

[HTML][HTML] Spectrum of BRAF aberrations and its potential clinical implications: insights from integrative pan-cancer analysis

Q Yi, J Peng, Z Xu, Q Liang, Y Cai, B Peng… - … in Bioengineering and …, 2022 - frontiersin.org
B-Raf proto-oncogene serine/threonine-protein kinase (BRAF) is frequently altered in
multiple cancer types, and BRAF V600 mutations act as a prime target for precision therapy …

[HTML][HTML] Active surveillance for low-risk thyroid cancers: a review of current practice guidelines

MJ Kim, JH Moon, EK Lee, YS Song… - Endocrinology and …, 2024 - ncbi.nlm.nih.gov
The indolent nature and favorable outcomes associated with papillary thyroid
microcarcinoma have prompted numerous prospective studies on active surveillance (AS) …

[HTML][HTML] Active surveillance for low-risk papillary thyroid carcinoma as an acceptable management option with additional benefits: a comprehensive systematic review

JH Yoon, W Choi, JY Park, AR Hong… - Endocrinology and …, 2024 - synapse.koreamed.org
Background Active surveillance (AS) has been introduced as a management strategy for low-
risk papillary thyroid carcinoma (PTC) due to its typically indolent nature. Despite this, the …